Microdosing may not produce the same level of weight loss seen with standard dosing, and outcomes depend on individual factors and medical oversight
Akimoto H, Tezuka K, Nishida Y, Nakayama T, Takahashi Y, Asai S
Currently, oral PYY analogs have entered preclinical research stages, with preliminary results showing they can effectively reduce food intake in mice and improve glucose tolerance (156, 162)
These issues occurred in 86% of patients on the drug versus 31% on placebo
I do recommend choosing meals that are higher in protein as well as utilizing additional high-protein foods to support your nutritional needs
Clinical research has shown that GLP-1based weight management programs, when combined with lifestyle modifications such as nutrition and movement, can lead to meaningful weight loss and improvements in metabolic health